Matches in SemOpenAlex for { <https://semopenalex.org/work/W1551153105> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W1551153105 endingPage "1" @default.
- W1551153105 startingPage "1" @default.
- W1551153105 abstract "Vascular changes are consistent early findings in patients with SSc and often precede the development of fibrosis. Despite a significant reduction in the capillary density, there is paradoxically no sufficient angiogenesis in the skin of SSc patients. By using a pO2 histograph, we showed that low pO2 values are overt in involved skin of patients with SSc. In vitro, real-time PCR revealed a 3.7-fold upregulation of the potent angiogenic growth factor VEGF in SSc fibroblasts after hypoxic exposure compared to normoxic controls. In situ hybridization for VEGF in skin biopsies of patients with SSc showed an overexpression of VEGF mRNA by fibroblasts and mononuclear infiltrates, whereas its expression was limited to keratinocytes in healthy control biopsies. In contrast to the SSc skin, HIF-1 alpha protein was found to be coexpressed with VEGF in healthy skin samples, indicating that the constitutive VEGF synthesis in the skin is driven by this transcription factor. Additionally, we showed that the lack of angiogenesis in SSc is not due to a reduced bioavailability of the overexpressed VEGF, since the VEGF receptors Flk-1 and Flt-1 were found to be expressed on endothelial cells of patients with SSc, but not in healthy controls, and since SSc patients had severely elevated serum levels of VEGF compared to healthy controls. Despite the enhanced levels of VEGF, serum samples of SSc patients did not induce angiogen-esis in the vivo chorion allantois membrane assay, indicating that the proangiogenic effects of VEGF may be outweighed by angiostatic factors. The hypothesis that VEGF synthesis has to be above an individual threshold in SSc patients to induce angiogenesis was further strengthened by the finding that patients without fingertip ulcers had significantly higher levels than patients with fingertip ulcers. Interestingly, the angiostatic factor endostatin was elevated in a subset of patients and thus may counteract directly the biologic effects of VEGF in SSc patients. Serum levels of VEGF were also correlated significantly with disease severity parameters including antitopoisomerase antibodies. These results suggest that therapeutic application of VEGF by either gene transfer or as a recombinant protein might be a novel option in SSc." @default.
- W1551153105 created "2016-06-24" @default.
- W1551153105 creator A5008497977 @default.
- W1551153105 creator A5013040378 @default.
- W1551153105 creator A5014391609 @default.
- W1551153105 creator A5018529897 @default.
- W1551153105 creator A5023554448 @default.
- W1551153105 creator A5032681915 @default.
- W1551153105 creator A5072819283 @default.
- W1551153105 creator A5084434161 @default.
- W1551153105 date "2002-01-01" @default.
- W1551153105 modified "2023-09-24" @default.
- W1551153105 doi "https://doi.org/10.1186/ar433" @default.
- W1551153105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3238211" @default.
- W1551153105 hasPublicationYear "2002" @default.
- W1551153105 type Work @default.
- W1551153105 sameAs 1551153105 @default.
- W1551153105 citedByCount "7" @default.
- W1551153105 countsByYear W15511531052015 @default.
- W1551153105 countsByYear W15511531052017 @default.
- W1551153105 countsByYear W15511531052018 @default.
- W1551153105 countsByYear W15511531052021 @default.
- W1551153105 crossrefType "journal-article" @default.
- W1551153105 hasAuthorship W1551153105A5008497977 @default.
- W1551153105 hasAuthorship W1551153105A5013040378 @default.
- W1551153105 hasAuthorship W1551153105A5014391609 @default.
- W1551153105 hasAuthorship W1551153105A5018529897 @default.
- W1551153105 hasAuthorship W1551153105A5023554448 @default.
- W1551153105 hasAuthorship W1551153105A5032681915 @default.
- W1551153105 hasAuthorship W1551153105A5072819283 @default.
- W1551153105 hasAuthorship W1551153105A5084434161 @default.
- W1551153105 hasBestOaLocation W15511531051 @default.
- W1551153105 hasConcept C41008148 @default.
- W1551153105 hasConceptScore W1551153105C41008148 @default.
- W1551153105 hasIssue "Suppl 1" @default.
- W1551153105 hasLocation W15511531051 @default.
- W1551153105 hasLocation W15511531052 @default.
- W1551153105 hasOpenAccess W1551153105 @default.
- W1551153105 hasPrimaryLocation W15511531051 @default.
- W1551153105 hasRelatedWork W2096946506 @default.
- W1551153105 hasRelatedWork W2130043461 @default.
- W1551153105 hasRelatedWork W2350741829 @default.
- W1551153105 hasRelatedWork W2358668433 @default.
- W1551153105 hasRelatedWork W2376932109 @default.
- W1551153105 hasRelatedWork W2382290278 @default.
- W1551153105 hasRelatedWork W2390279801 @default.
- W1551153105 hasRelatedWork W2748952813 @default.
- W1551153105 hasRelatedWork W2899084033 @default.
- W1551153105 hasRelatedWork W3004735627 @default.
- W1551153105 hasVolume "4" @default.
- W1551153105 isParatext "false" @default.
- W1551153105 isRetracted "false" @default.
- W1551153105 magId "1551153105" @default.
- W1551153105 workType "article" @default.